Artwork

Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S8 Ep2: Exploring AI Innovation: insitro CEO Daphne Koller On AI In Drug Discovery

39:10
 
Share
 

Manage episode 469784481 series 3317342
Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.
  continue reading

49 episodes

Artwork
iconShare
 
Manage episode 469784481 series 3317342
Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.
  continue reading

49 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play